✦ LIBER ✦

The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease

✍ Scribed by Irene Mitchell; N. Deshpande; Rosemary Millis; R. D. Rubens

Publisher: Springer
Year: 1986
Tongue: English
Weight: 269 KB
Volume: 17
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00256702

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Response to second-line chemotherapy in

Response to second-line chemotherapy in patients with metastatic breast carcinoma previously responsive to first-line treatment : Prognostic factors

✍ Bernard Brun; Mohamed Benchalal; Christelle Lebas; Pascal Piedbois; Ma Lin; Jean 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

tic factors associated with response to a second-line chemotherapy in patients with metastatic breast carcinoma (MBC) that was previously responsive to a first-

Phase II study of paclitaxel in patients

Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy

✍ Edgardo Rivera; Frankie A. Holmes; Debra Frye; Vicente Valero; Richard L. Theria 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

Extreme drug resistance assay and respon

Extreme drug resistance assay and response to chemotherapy in patients with primary peritoneal carcinoma

✍ Eltabbakh, Gamal H. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 92 KB 👁 2 views

## Background and Objectives: The extreme drug resistance (EDR) assay is an in vitro chemoresistance assay performed on tumor samples grown in culture and is claimed to predict drugs unlikely to produce response. Its clinical value in patients with epithelial ovarian cancer (EOC) has recently been

Apoptosis and proliferation as predictor

Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma

✍ J. Chang; M. Ormerod; T. J. Powles; D. C. Allred; S. E. Ashley; M. Dowsett 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 2 views

Concordance in pathological response to

Concordance in pathological response to neoadjuvant chemotherapy between invasive and noninvasive components of primary breast carcinomas

✍ Kaneyuki Matsuo; Takashi Fukutomi; Toru Watanabe; Tadashi Hasegawa; Hitoshi Tsud 📂 Article 📅 2002 🏛 Springer Japan 🌐 English ⚖ 938 KB

The response to further chemotherapy in

The response to further chemotherapy in patients with carcinoma of the breast who progressed while receiving adjuvant therapy

✍ Don M. Morris; E. George Elias; Mukund S. Didolkar; Sally D. Brown 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 350 KB

The effect of known chemotherapeutic programs in patients with breast cancer who developed metastasis during or after adjuvant chemotherapy with L-PAM plus 5-FU (PF) were studied. Thirteen patients failed while receiving adjuvant therapy at 3-22 months from the time therapy started. Three patients f